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A Silent Enzootic of an Orthopoxvirus in Ghana, West Africa: Evidence for Multi-Species
Involvement in the Absence of Widespread Human Disease
Mary G. Reynolds,*† Darin S. Carroll,† Victoria A. Olson, Christine Hughes, Jack Galley, Anna Likos,
Joel M. Montgomery, Richard Suu-Ire, Mubarak O. Kwasi, J. Jeffrey Root, Zach Braden, Jason Abel,
Cody Clemmons, Russell Regnery, Kevin Karem, and Inger K. Damon
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Ghana Health Service,
Ghana Ministry of Health, Accra, Ghana; Wildlife Division of the Forestry Commission, Accra, Ghana; Virology Department,
Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana;
United States Department of Agriculture, National Wildlife Research Center, Fort Collins, Colorado

Abstract. Human monkeypox has never been reported in Ghana, but rodents captured in forested areas of southern
Ghana were the source of the monkeypox virus introduced into the United States in 2003. Subsequent to the outbreak in
the United States, 204 animals were collected from two commercial trapping sites in Ghana. Animal tissues were examined for the presence of orthopoxvirus (OPXV) DNA using a real-time polymerase chain reaction, and sera were assayed
for antibodies against OPXV. Animals from five genera (Cricetomys, Graphiurus, Funiscirus, and Heliosciurus) had antibodies against OPXV, and three genera (Cricetomys, Graphiurus, and Xerus) had evidence of OPXV DNA in tissues.
Additionally, 172 persons living near the trapping sites were interviewed regarding risk factors for OPXV exposure, and
their sera were analyzed. Fifty-three percent had IgG against OPXV; none had IgM. Our findings suggest that several species
of forest-dwelling rodents from Ghana are susceptible to naturally occurring OPXV infection, and that persons living near
forests may have low-level or indirect exposure to OPXV-infected animals, possibly resulting in sub-clinical infections.

ogy may exist in this country,9 and the purported source of the
virus introduced into the United States in 2003 was rodents
imported from Ghana.10,11 Fourty-seven confirmed and probable human infections were reported during the outbreak
in the United States and at least nine mammal species, representing Old World and New World species, were newly
recognized as being capable of hosting infections with monkeypox virus (MPXV).11 Members of three genera of African
rodent were implicated as the initial, inadvertent, source of
importation of the virus into the United States, these being
Cricetomys, Graphiurus, and Funisciurus (commonly known
as giant pouched rat, African dormouse and rope squirrel,
respectively).11 Multiple individuals of each of these types of
animal were captured in Ghana and sent to the United States
for sale as pets. The animals arrived in a single consignment
on April 21, 2003. Because the animals had been housed near
each another before and during transport to the United States,
it was impossible to determine at what point each of the different types of animals might have become infected and which, if
any, might have harbored the virus at their time of capture.
To determine the precise geographic origin of the infected
animals and to assess whether one or more of the three implicated species might harbor MPXV in nature, we traveled to
the area in which the animals were originally trapped and
collected additional specimens (from the same time of year),
which could then be tested for MPXV. Furthermore, we examined residents of nearby communities for serologic evidence of
orthopoxvirus (OPXV) exposure to determine to what extent
persons living near these animals might be exposed to the
virus. The findings of these investigations are detailed below.

INTRODUCTION
The first case of human monkeypox (MPX) was identified
in 1970 in the Basankusu District of the Democratic Republic
of the Congo (former Zaire) during the intensification phase
of the smallpox eradication campaign.1 In that same year, five
additional MPX cases were reported in west Africa, four in
Liberia and one in Sierra Leone.2,3 However, during the subsequent 13 years, only 11 of the 155 MPX cases identified
in Africa were reported from west Africa countries (Côte
d’Ivoire, Liberia, Nigeria, Sierra Leone);4 most cases occurred
in the Democratic Republic of the Congo.
The natural cycle of MPX within its native range is poorly
understood, as is the route of transmission to humans in the
tropical forest setting. The only MPX virus isolated from a
wild-caught mammal was obtained from a single moribund
rope squirrel (Funisciurus anerythrus) collected during an
outbreak investigation in Zaire.5 Primary human (and nonhuman primate) infections are hypothesized to result from
contact with an infected sylvan animal, although this reservoir
host species is currently unknown.
Most of the previous field investigations designed to identify
the sylvatic reservoir of MPX virus were confined to relatively
short-term outbreak responses and involved general broad
spectrum collections of a wide variety of mammalian taxa. The
taxa and animals examined were mostly composed of those
species that can be purchased from local hunters and collectors. Such taxonomically broad surveys yield large numbers of
samples, but usually do not sufficiently sample any individual
taxon given the likelihood of a low incidence of active infections in presumptive reservoir species.6–8
Human MPX has never been described in Ghana, although
ecologic niche models predict limited regions of suitable ecol-

METHODS
Animal collections. The origin of the MPXV-infected
animals imported into the United States on April 21, 2003, was
traced to a single facility in Accra, Ghana. A description of
husbandry practices at the facility was undertaken by officials
from the Ghanaian Wildlife Division in cooperation with the
owner, focusing on animal housing, turnover, shipping, and

* Address correspondence to Mary G. Reynolds, Division of Viral and
Rickettsial Diseases, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop G-43 Atlanta, GA 30333. E-mail:
nzr6@cdc.gov
† These authors contributed equally to this article.

746

ORTHOPOXVIRUSES IN GHANA

other practices that could have influenced virus transmission
among captive animals.
Two localities outside Accra were identified by the facility
owner as being the areas from which the original animals from
the April 2003 shipment had been collected. One site (5.98125N,
0.58489E) was near the town of Sogakofe, in the Volta region
and the other site (5.78562N, 1.01410W) was near the city of
Oda in the Eastern region. In March–April, 2004, animals representing several of the species contained in the 2003 consignment and others commonly found in the two source areas were
collected and evaluated for the presence of MPXV and for
serologic evidence of prior or current infection.
The collection and processing of animals followed Methods
for Trapping and Sampling Small Mammals for Virologic Testing
published by the Centers for Disease Control and Prevention
(CDC). Live animals were handled according to guidelines
and recommendations of the CDC Institutional Animal Care
and Use Committee and as outlined in The Institutional
Animal Care and Use Committee protocol Field Collections
in Zoonoses Investigations. Small rodents were either trapped
live by using live traps (H. B. Sherman Traps, Tallahassee, FL)
and locally produced live traps or were captured live by hand.
Gross pathologic examinations were followed by a complete
necropsy in which blood, heart, liver, kidney, lung, spleen, and
skin samples were collected and immediately frozen at −20°C
before being transferred to dry ice coolers. Specimens were
split, with half remaining at the Noguchi Memorial Institute
for Medical Research in Accra and half sent to CDC laboratories in Atlanta.
The CDC laboratories in Atlanta evaluated tissue specimens for evidence of OPXV and MPXV (by using a polymerase chain reaction [PCR] and virus culture) and assayed
blood specimens for antibodies (by using an enzyme-linked
immunosorbent assay [ELISA]).
Serosurvey. Residents living in villages near the two original
trapping sites were contacted by Ghanaian Ministry of Health
officials and CDC investigators and asked to participate in a
research study to evaluate human exposure to OPXV species.
Local Ministry of Health workers explained the purpose of
the study and read the consent form to prospective enrollees,
translating from English when necessary. Parental consent was
obtained for persons less than 18 years of age. Adolescents
(age = 11–17 years) and children (age = 7–10 years) were asked
to provide their assent to participate in the study.
Persons who consented to participate were asked to provide
basic demographic information (e.g., age, occupation) and to
answer several questions pertaining to illness history, smallpox vaccination status, and exposure to wildlife. In addition,
one blood specimen was collected from each study participant.
Blood for serologic testing was collected in standard marbletop vacutainer™ tubes and stored refrigerated for not more
than 48 hours before being centrifuged. Centrifugation and
collection of serum was conducted at the Noguchi Memorial
Institute for Medical Research. Serum specimens were divided
and frozen; one aliquot was kept at the Ministry of Health
laboratories and one was sent to CDC for analysis of OPXVreactive IgG and IgM.
Persons who participated were compensated for their time
and effort. The protocol for this study was reviewed and
approved by institution review boards at the CDC in Atlanta
(CDC protocol #4043) and at the Noguchi Memorial Institute
for Medical Research in Accra.

747

Laboratory methods. Detailed methods for preparation
and analysis of tissues using real-time PCR are described
elsewhere.11 All processing of animal tissues was performed
under BioSafety Level 3 conditions. Solid tissues (pooled or
individual) were placed in disposable dounce homogenizers
(Kendall Large Tissue Grinders; Kendall Company catalog no.
3500SA; Tyco Healthcare, Mansfield, MA). One milliliter of
phosphate-buffered saline was added to each measured tissue
sample before grinding to enable creation of slurries. Genomic
DNA was prepared from an aliquot of each slurry (kit catalog
no. 732-6340; Bio-Rad, Hercules, CA). Remaining tissue slurries were stored for future virus isolation (see below).
Nucleic acid samples prepared from pooled tissues were
tested by real-time PCR for OPXV DNA before testing individual tissues. The primer/probe sequences were selected from
the DNA polymerase gene (E9L; GenBank accession no.
L22579) with Primer Express version 1.5 (Applied Biosystems,
Foster City, CA). These sequences included OPX forward
primer (5′-TCA AAT ATT GAT CGT CCA ACG A-3′), OPX
reverse primer (5′-TGG ATG AAT TTC TCA ATA TTA GTT
GG-3′), and OPX probe (5′FAM-TAA CAT CCG TCT GGA
GAT ATC CCG TTA GA-BHQ1-3′). Primers and probe
were synthesized in the Biotechnology Core Facility (CDC)
by using standard phosphoramidite chemistry. Each reaction
(25 μL) contained 5 μL of template DNA, 0.5 μL of each
primer, 0.5 μL probe added to the LightCycler FastStart DNA
Master HybProbe (2.5 μL vial 1 [DNA polymerase], 3 μL vial 2
[25 mM MgCl2], and 10.25 μL vial 3 [water]; Roche, Indianapolis,
IN) and TaqMan Exogenous Internal Positive Control (2.5 μL
10× Internal Positive Control Mix and 0.25 μL 50× Internal
Positive Control DNA; Applied Biosystems). Thermal cycling
conditions for the ABI7900 apparatus (Applied Biosystems)
were one cycle at 95°C for 10 minutes and 45 cycles at 95°C
for 15 seconds and 60°C for 1 minute. The PCR amplification
is based on fluorescent emission after annealing/elongation
(60°C).
Each reaction in the real-time assay was performed in triplicate, and the operator was blinded to the identity of the source
DNA. Vaccinia virus Wyeth DNA (50 fg) was used as a positive control and six wells with water were used as negative
controls. In all wells, the ABI TaqMan exogenous internal positive control DNA (Applied Biosystems) and primers/probe
mixture was included to assay for PCR inhibition that may be
caused by the sample. Any tissue pool showing a positive result
in the assay was further analyzed at the level of individual
tissue (i.e., samples of kidney, eyelid, tongue, brain, blood,
heart, liver, gonad, lesion, oral swab, ocular swab, lymph node,
feces, skin, and urine). Specimens from individual tissues that
had positive results were also analyzed for MPXV-specific
DNA signatures (targeting the B6R gene encoding an envelope protein12), and an aliquot of the sample slurry was used
for virus isolation on cultured BSC-40 cells. Reproducibly
positive samples were additionally analyzed for a secondary
OPXV DNA sequence (14-kD fusion protein, A27L) by using
the Artus Orthopox LC PCR kit (Qiagen, Valencia, CA).13
Tissue specimens for which positive results were not reproducible were scored as equivocal; further analysis was not
attempted on these specimens. A modified OPXV ELISA was
used for animal screening.11,14
Human serum samples were assessed for IgG and IgM
reactive with OPXV antigen in accordance with published
methods.14 Antibody positivity was measured and compared
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with reference standards. Any reading that was three standard deviations above the mean of the negative controls was
inferred to be positive.
Statistical analyses. Epidemiologic and demographic
variables and qualitative laboratory findings were analyzed
by using parametric and nonparametric statistical tests.
Nonparametric statistical tests were used when analyzing
subsets of data that were not normally distributed. The
Mantel-Haenszel common odds ratio (OR) and Fisher’s exact
tests (two-tailed) were used for categorical variables, and the
Student’s t-test was used for comparison of means derived
from continuous variables. A P value < 0.050 was used to
measure significance of associations.
RESULTS
Investigation of export facility. Interviews with the U.S.
importer and the licensed commercial Ghanaian exporter
indicated that in March–April 2003 collections of multiple
Ghanaian mammal species were made by local persons. These
animals were subsequently shipped to the United States.
The shipment included several rodent species including
Gambian rats (Cricetomys spp.), rope squirrels (Funisciurus
spp.), dormice (Graphiurus spp.), sun squirrels (Heliosciurus
spp.), striped mice (Lemiscomys barbarus), and brush-tailed
porcupines (Atherurus africanus). These collections were
made gradually over a period of a few weeks. While awaiting
shipment, the pouched rats were stored together in concrete
enclosures and the squirrels were housed in contiguous wire
mesh cages with several individuals per cage. All animals
were grouped with members of their own species. Most of
the squirrels, and pouched rats were collected in a forest
zone northwest of Accra (Figure 1). The potential of a
second collection site for at least one of the Genera collected
(Cricetomys) could not be ruled out by the Ghanaian exporter.
The dormice were collected from a lowland scrub vegetation
area near the Volta River northeast of Accra. These two sites
are separated by approximately 200 miles (Figure 1).
The animal shipments were packed into multi-tiered wooden
crates with wire-lined compartments. Members of each of the
smaller species (Lemniscomys and Graphiurus) were shipped
with approximately 25 animals per compartment. The exporter
reported seeing nothing unusual as far as overt disease in the
animals before shipment, nor were any unusual animal dieoffs seen at his facility before shipment. The shipment was sent
as freight aboard a commercial airline and entered the United
States through Dallas, Texas.
Animals collected during the investigation. To determine
which species of interest might be capable of harboring MPXV
in nature, members of the Ghanaian Division of Wildlife
Services, CDC, the U.S. Department of Agriculture, and local
trappers collected 204 animals over nine nights during March
24–April 2, 2004. Approximately 28% (57 animals) were
collected in the Eastern region and the remaining from the
Volta region (Table 1). All were apparently healthy adult or
sub-adult animals.
Among 182 animals for which serologic analysis was
performed, only 2 (one a Cricetomys sp. and the other a
Funisciurus sp.) had detectable levels of antibodies against
OPXV at the highest reciprocal serum dilution of 400 (Table 1).
One additional Funisciurus sp. and one Gambian Sun squirrel
(Heliosciurus gambianus) had low levels of antibodies against

Figure 1. Map of Ghana, showing the two survey locations.

OPXV. Moderate levels of antibodies against OPXV were
detected in two Graphiurus spp. (at a reciprocal dilution of
200), and seven others had low levels of antibodies.
Using the molecular screening algorithm outlined above, we
found that 6 of 97 Graphiurus, 2 of 38 Cricetomys, and 1 of
1 Xerus showed evidence of OPXV DNA signatures in harvested tissue specimens (Table 2). An additional 26 other animals, 13 Graphiurus, 9 Cricetomys, 3 Funiciurus, and 1 Xerus,
showed equivocal results.
Tissues from the nine animals that showed positive results
by real-time PCR specific for OPXV (generic) polymerase
(E9L) DNA signatures were also assayed for a secondary
OPXV DNA target (14-kD fusion protein). Three of the nine
animals were also positive for this secondary OPXV (Xerus
289, Graphiurus 389, and Graphiurus 431) (Table 2). All animals were subsequently screened for MPXV-specific signatures by using a real-time PCR designed to detect sequences
corresponding to the MPXV envelope protein (B6R). The
MPXV-specific DNA signals were not reproducibly detected
in any of the specimens. However, the MPXV-specific assay
is slightly less sensitive than the OPXV generic A27L assay
(10 genomes versus 4 genomes, respectively).12,13 A cytopathic
effect caused by OPXV was not observed in virus cultures
prepared from the tissues of any animals, nor was culturable
virus obtained after serial passage. (In our hands, virus culture
is typically 10–100-fold less sensitive than the most sensitive
real-time PCR in detecting OPXV in clinical specimens.)
One Graphiurus spp. (animal number 431) had a low level
of antibodies against OPXV in its serum and OPXV DNA
signatures in its spleen. Two Funisciurus spp. with antibodies
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Table 1
Results of laboratory testing to detect presence of orthopoxvirus DNA and antibody against orthopoxvirus from tissue and blood specimens of
rodents collected in two regions of Ghana*
Orthopoxvirus DNA detection by real-time PCR†

Orthopoxvirus antibody ELISA endpoint titers

Genus

No.

Region

Positive‡

Equivocal§

Negative

% Positive

1:50

1:100

1:200

1:400

No. tested

Graphiurus
Cricetomys
Lemniscomys
Tatera
Funiscirus
Mus
Heliosciurus
Arvicanthis
Xerus

100
40
24
9
9
8
7
6
1

Volta
Eastern
Volta
Volta
Eastern
Volta
Eastern
Volta
Eastern

6
2
0
0
0
0
0
0
1

13
9
0
0
3
0
0
1
0

78
27
24
9
6
8
4
6
0

6
5
0
0
0
0
0
0
100

7¶
0
0
0
1
0
1
0
0

0
0
0
0
0
0
0
0
0

2
0
0
0
0
0
0
0
0

0
1
0
0
1
0
0
0
0

90
38
20
9
5
8
7
4
1

* PCR = polymerase chain reaction; ELISA = enzyme-linked immunosorbent assay.
† The orthopoxvirus DNA detection threshold for the orthopoxvirus generic E9L polymerase real-time PCR assay is ≥ 2 fg of purified vaccinia DNA.
‡ Result replicated in independent assay; represents finding from liver, spleen, skin, and/or pooled organ specimens. Details are shown in Table 2.
§ < 3 of 3 replicated positive for pooled organ specimen.
¶ Female dormice were significantly more likely to have Opx-reactive titers at 1:50 than males (P = 0.030, by Fisher’s exact test, 2-sided).

against OPXV had equivocal OPXV DNA findings in pooled
organ specimens in the PCR screening.
Human serosurvey. To investigate whether persons working
closely with sylvan animals and humans living near animal
trapping sites might be at enhanced risk for exposure to OPXVs,
we conducted a serosurvey among residents of several villages
within walking distance of where the animals implicated in the
U.S. outbreak had been originally collected. For purposes of this
study, these villages will be referred to as villages A/B (Eastern
region) and Village C (Volta region). In all, 65 residents of
village C (approximately 92% of the total village population),
100 residents of villages A/B (approximately 33% and 85% of
the total village populations, respectively), and 7 persons who
were directly involved in the exotic animal trade consented
to participate in the serosurvey (Table 3). The sex distribution
and occupations of study participants were similar between the
Eastern Region and Volta region survey sites, but the proportion
of persons greater than 23 years of age enrolled from the Volta
region was higher than that from the Eastern region.
Most village residents reported that they entered the forest
at least once a week (98% and 95% for villages A/B and C,
respectively), whereas five of six of those actively engaged
in the animal trade reported only going into the forest on a
monthly basis. Cultivation and firewood collection were cited
most frequently as the principal reason for participants going
into forested areas (n = 76 [71%] and n = 28 [26%], respectively), among those 107 participants who provided a response
to the question. A higher proportion of men than women cited
cultivation as the reason for entering the forest (67% versus

33%, respectively); this bias was of similar proportion in the
Eastern and Volta regions. Other reasons cited for forest entry
were animal trapping related activities (n = 2) and accompanying adults (n = 1).
All enrolled study participants provided blood for quantification of IgG and IgM against OPXV. Serologic tests used in
this study do not detect specific antibodies against MPXV but
do detect antibodies broadly cross-reactive against antigens
from multiple OPXVs, including MPXV and vaccinia virus
(the live virus component of the smallpox vaccine).
None of the study participants had positive results for IgM
against OPXV, which suggested that none had been exposed
to an OPXV (for which they had been previously immunologically negative) within the prior two months.14 However, 91
(53%) study participants had detectable levels of IgG against
OPXV (Figure 2A). A higher proportion of those greater than
23 years of age, as opposed to those younger, had detectable
IgG against OPXV (n = 51 [81%] versus n = 40 [37%], respectively). This finding is consistent with the fact that many of the
older persons in this study would likely have had the opportunity to have received smallpox vaccination (or may even have
been exposed to variola virus before smallpox eradication).
Smallpox vaccination typically results in life-long persistence
of IgG against OPXV. The 24 study participants who reported
having received smallpox vaccination at some point in life all
had detectable IgG against OPXV and visible vaccination
scars; all were greater than 23 years of age.
The proportion of adults (greater than 23 years of age) with
positive findings for IgG against OPXV was relatively similar

Table 2
Characteristics of animals that had evidence of infection with orthopoxvirus, Ghana*
Genus and animal

Sex

Age

Graphiurus 326
Graphiurus 369
Graphiurus 389

M
M
F

Adult
Adult
Adult

Graphiurus 404
Graphiurus 431
Graphiurus 485

M
F
F

Adult
Adult
Adult

Cricetomys 459
Cricetomys 460
Xerus 289

F
F
F

Sub-adult
Sub-adult
Adult

Tissue

E9L PCR

A27L PCR

Orthopoxvirus ELISA titer 1:50

Pool
Pool
Spleen
Liver
Lung
Spleen
Skin
Pool
Spleen
Spleen
Spleen

Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive

Negative
Negative
Positive
Negative
Negative
Positive
ND
Negative
Negative
Negative
Positive

Negative
Negative
Negative
Negative
Negative
Positive
Negative
Negative
Negative
Negative
Negative

* PCR = polymerase chain reaction; ELISA = enzyme-linked immunosorbent assay; ND = not determined.
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Table 3
Characteristics of persons from the Eastern and Volta regions of Ghana who participated in the serosurvey
Category No. (%)
Characteristic

Eastern region resident

Volta region resident

Exotic animal professional

Total (%)

Total
Sex
M
F
Age, years*
≤ 23
> 23
Prior smallpox vaccination†
Yes
No
Occupation
Exotic animal trader
Farmer
Commercial
Child/student
Forest visits‡
At least once a week
At least once a month

100 (100)

65 (100)

7 (100)

172 (100)

54 (54)
46 (46)

37 (57)
28 (43)

6 (86)
1 (14)

97 (56)
75 (44)

70 (70)
30 (30)

35 (54)
30 (46)

4 (57)
3 (43)

109 (64)
63 (36)

11 (11)
89 (89)

12 (19)
52 (81)

1 (14)
6 (86)

24 (14)
147 (86)

–
30 (30)
1 (1)
69 (69)

–
30 (46)
–
35 (54)

7 (100)
–
–
–

7 (4)
60 (35)
1 (1)
104 (60)

95 (97.9)
2 (2.1)

61 (95.3)
3 (4.7)

1 (14.3)
6 (85.7)

157 (93.5)
11 (6.5)

* Routine smallpox vaccinations in Africa ceased in 1982. Persons less than 24 years of age at time of enrollment in this study were not expected to have had the opportunity for childhood vaccination to protect against smallpox.
† Vaccination status is based on self-reporting. Vaccination scars were noted in 22 (92%) of 24 persons who provided a self-report of smallpox vaccination; one person from the Volta region with
evidence suggestive of a vaccination scar denied having been vaccinated. This person was not included in either category.
‡ Four persons enrolled in the study did not provide information pertaining to frequency of forest visits.

in study participants from the Eastern and Volta regions (87%
and 77%, respectively). However, among persons ≤ 23 years
of age, there was a significantly greater probability of a positive finding for IgG against OPXV among those living in the
Eastern region (OR = 4.05, 95% confidence interval [CI] =
1.50–11.03) (Table 4 and Figure 2B). Those persons engaged
in the exotic animal trade were not more likely to have IgG
against OPXV than village residents (independent of age).
Sex or reported frequency of visits into forested areas were
not individually associated with IgG against OPXV.
The principal reason persons cited for going into the forest was associated with status of IgG against OPXV, but in

an age-delimited fashion. It has been estimated that half of
boys and girls 10–14 years of age in Ghana are substantively
engaged in farming and domestic work, which is double the
proportion of those 7–9 years of age involved in these activities.15 Among study participants greater than nine years of age
(persons anticipated to have significant levels of engagement
in the activity cited) with no history of smallpox vaccination,
cultivation, rather than firewood collection, was found to be
significantly associated with IgG against OPXV (OR = 3.24,
95% CI = 1.00–10.47) (Table 4).
Evaluation of absolute levels of IgG against OPX in the study
population showed that in persons ≤ 23 years of age, levels

Figure 2. Levels of serum IgG against orthopoxvirus (OPXV) (OD-COV) among study participants in Ghana, by age and region. A, Scatterplot
depicting OPXV IgG levels by age (years) across the study population. Blue = Easter region; cyan = Volta region; red = persons engaged in exotic
animal trade. B, Histograms showing the distribution of OD-COV values among persons ≤ 23 years of age, stratified by region, including persons
≤ 23 years of age engaged in exotic animal trade.
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Table 4
Characteristics associated with IgG against orthopoxvirus among study participants*
Orthopoxvirus ELISA
Characteristic

≤ 23 years of age†
Eastern
Volta
> 23 years of age
Eastern
Volta
Professional animal worker
≤ 23 years of age
> 23 years of age
Primary reason for forest visits†
Cultivation
Firewood

No. (%) positive

No. (%) negative

OR (95% CI)

32 (84.2)
6 (15.8)

38 (56.7)
29 (43.3)

4.07 (1.50–11.03)
–

26 (53.1)
23 (46.9)

4 (36.4)
7 (63.6)

1.98 (0.51–7.63)
–

2 (50)
2 (50)

2 (66.7)
1 (33.3)

–
–

31 (86.1)
5 (13.9)

23 (65.7)
12 (34.3)

3.24 (1.00–10.47)
–

* ELISA = enzyme-linked immunosorbent assay; OR = odds ratio; CI = confidence interval.
† Among persons > 9 years of age with no history of smallpox vaccination.

were substantially below that which would be anticipated in
persons with recent acute infection with OPXV (Figure 3). To
assess whether the relatively low ELISA optical density values
observed in positive for IgG against OPXV across the study
population were greater than would be expected from a known
OPXV-negative population, the mean OPXV IgG level among
IgG-positive persons ≥ 23 years of age from Ghana (the group
with the lowest serum level of IgG against OPXV [OD-COV],
n = 40) was compared with that of specimens obtained from
persons not vaccinated against smallpox in the United States

(persons ruled out for MPXV infection in 2003 by clinical, epidemiologic, and laboratory criteria, n = 74).16 Although substantially lower than the mean OD-COV for persons acutely
infected with MPXV and persons one year post-infection, the
mean OD-COV for IgG-positive Ghanaians ≤ 23 years of age
(OD-COV = 0.17) was significantly higher than that for OPXVnegative persons in the United States (OD-COV = −0.05; P <
0.001 by two-sided Student’s t-test, degrees of freedom = 41).
Although overall levels of IgG against OPXV among IgGpositive persons in this study were low relative to what is typically observed within one year of acute OPXV infection, six
persons in this study showed highly elevated levels of IgG
against OPXV (defined here as OD-COV > 2 standard deviations above the mean of the IgG-positive population in the
study). All of these persons were greater than 23 years of age
and described themselves as farmers. Five were from the Volta
region; they reported having received smallpox vaccinations.
One was from the Eastern region; this person did not report
receiving a smallpox vaccination and had no evidence of a vaccine-associated scar.
DISCUSSION

Figure 3. Box plots of levels of serum IgG against orthopoxvirus
(OPXV) (OD-COV) for A, non–smallpox-vaccinated persons who
were not infected with monkeypox virus (MPXV) infection by clinical, epidemiologic, and laboratory criteria during the MPX outbreak
in United States in 2003 (n = 74); B, persons positive for IgG against
OPXV ≤ 23 years of age in this study (n = 40); C, persons confirmed
as having MPXV infection during the U.S. outbreak approximately
one year post-illness onset (n = 14); and D, persons confirmed as having MPXV infection during the U.S. outbreak with acute-phase illness
(n = 15).16 This figure appears in color at www.ajtmh.org.

Somewhat contrary to expectations, our results did not
implicate a single species of animal as being the sylvan source
of MPXV for the U.S. outbreak. We found evidence suggestive
of intermittent exposure to OPXVs among various species
across a broad geographic span. Species of animal showing
evidence of OPXV exposure (i.e., Cricetomys spp., Graphiurus
spp., Funiscuris spp., Xerus spp.) mirrored those implicated
in the U.S. outbreak,11 with the exception of the Xerus spp.,
which had not previously been associated with OPXV exposure. It should be emphasized that our study was not intended
to constitute a comprehensive survey of the sylvan fauna of
Ghana for evidence of OPXV infection. Only rodent species were evaluated. Species implicated in the U.S. outbreak
were preferentially collected. Many of the species were sampled below the threshold needed to determine whether their
OPXV nucleic acid and seroprevalence rates were comparable to those observed for Graphiurus spp., the most well sampled species (for which nucleic acid and antibody prevalence
rates of 6.2% and 10%, respectively, were observed).
If we assume that rodents, like humans, will sustain life-long
detectable OPXV antibody titers after infection, the relatively
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low seroprevalence rates observed for two of well sampled
species of interest, Graphiurus spp. and Cricetomys spp. (2.6%
and 10%, respectively), might indicate that these species are
unlikely to serve as natural sylvan reservoirs for OPXVs.
Members of the genus Funisciurus, which showed a seroprevalence of 40%, might be good candidates. The only isolation of
MPXV from an animal in the wild came from a Furnisciurus
anerythrus,5 further indicating the relevance of this species as
a putative maintenance source of the virus in nature. However,
studies of other, better-characterized, rodent-borne zoonotic
viruses have documented similarly low point seroprevalence
rates.17 Additionally, ecologic investigations of OPXVs from
Europe performed in the United Kingdom, which investigated the influence of cowpoxvirus infection on population
cycles in the reservoir host (the field vole Microtus agrestis),
have shown that population seroprevalence rates can vary
temporally, thus limiting the informational value of single
cross-sectional measurements to implicate, or rule out, virus
maintenance hosts.18 In one such study,19 sharp decreases in
seroprevalence were observed in bank vole populations that
had experienced recent demographic crashes. The investigators noted that in some instances population seroprevalence
decreased to undetectable levels after approximately two-fold
decreases in density during the period six months prior, and
conversely, reached as high as approximately 90% in the postrebound period (in delayed density-dependent fashion, with a
lag occurring between population rebound and increased seroprevalence). Therefore, understanding the interplay between
MPXV and the population dynamics of various candidate reservoir species will be crucial to arriving at an accurate interpretation of OPXV serologic and virologic findings.
Animal infection experiments that illuminate features of
virus transmission dynamics and pathobiology in various candidate reservoir species can also be helpful in identifying the
reservoir host, and differentiating it from other species that are
merely permissive of virus replication. The interpretation of
human serologic findings is similarly nuanced. Also, contrary
to expectations, the results of our study did not show enhanced
risk of OPXV exposure among persons directly involved in the
exotic animal trade. Instead, we observed IgG against OPXV
among a large proportion of those persons living in rural communities near the original animal trapping sites, albeit no
persons had serologic evidence suggesting recent infection.
Smallpox vaccination continued in Africa until 1980. Therefore,
a substantial proportion of persons greater than 23 years of age
at the time that this study was performed would be anticipated
to retain cross-reactive antibodies because of vaccination. The
presence of antibodies against OPXV in persons born after
cessation of vaccination is of somewhat greater interest. In this
study, 36% of young non-vaccinated persons had IgG against
OPXV. Within this group, mean values for absolute IgG (0.17,
95% CI = 0.12–0.22; derived from a single-dilution ELISA OD
values) decreased between those observed for OPXV-negative
persons (–0.05, 95% CI = –0.04 to –0.06) and those anticipated
for persons one year after having clinically defined MPXV
infection (0.80, 95% CI = 0.93–1.25) (Figure 3).
These comparison groups (OPXV-negative persons and persons with clinically defined MPXV infection) are derived from
investigations performed during the U.S. MPX outbreak.14,20
The constituent population for this study is different in many
ways from that that found in the United States, but in theory
members of both groups, those exposed to MPXV-infected

animals in the United States and Ghanaians living near the
animal trapping sites, would have had opportunities for exposure to the same strain of MPXV. The question of whether the
intermediate levels of seropositivity observed in many young
or otherwise unvaccinated persons in this study might be a
consequence of asymptomatic or sub-clinical infections with
this strain of MPXV is worthy of consideration. Asymptomatic
MPXV infections in members of young age groups have been
previously hypothesized,21 and three persons affected during the U.S. outbreak are presumed to have had sub-clinical
MPXV infections.22 However, all three of these persons had
had prior smallpox vaccination and each had a robust IgG
titer against OPXV.
Another possibility to account for intermediate levels of
seropositivity is that perhaps beginning at a young age, persons living in the areas surveyed may be exposed to other,
as yet uncharacterized, OPXVs that are non-pathogenic in
humans. Demonstration of this phenomenon emerged in the
1970s when Baxby and others23 demonstrated that young camels, which were fully susceptible to infection with camelpox
virus, could not be productively infected with variola virus.
However, exposure to variola virus by scarification resulted
in production of intermediate-level titers of antibodies against
OPXV in these animals,23 which were sufficient to provide
protection against subsequent challenge with camelpox virus.
Taterapox virus is one example of an OPXV that has been
identified in west Africa that has an unknown pathogenic
capacity in humans.24
In general, a broad comparison between the age-specific
seroprevalences seen in this study from Ghana versus one
performed in an MPXV-endemic setting in the Democratic
Republic of the Congo in 198121 showed similar progressive
increases in age-specific seroprevalence through successive
older age classes, but the overall proportion of seropositive
persons at each age class was considerably elevated in this
study as opposed to the former study. Similar to the study
in the Democratic Republic of the Congo, children in this
study from communities surrounded by dense forest (Eastern
region) had a significantly higher probability of being seropositive than did children from villages surrounded by mosaic
forest-savannah habitat. The habitats in these different areas
tend to support varied abundances of several common animal
species, including those species of rodent implicated in the
MPXV importation event to the United States; Funisciurus
spp. and Cricetomys spp. were more commonly trapped in the
Eastern locations and Graphiurus sp. was more commonly
trapped in the Volta Region. The potential for differing intensities of human exposure to rodent species harboring MPXV
exists between the two areas, but has yet to be demonstrated.
Cultivating crops in forested areas was also significantly associated with the presence of antibodies against OPXV (in nonvaccinated persons greater than nine years of age). This finding
could also be associated with enhanced opportunities for contact with sylvan rodents (crop pests). Alternatively, cultivation
activities could merely signal more frequent and longer durations of time spent by persons in a forested habitat.
The lack of an appropriate urban Ghanaian population
sample against which to compare human serologic findings
and risk factor data limits our ability to investigate absolute
risks for OPXV exposure attributable to living in rural communities. Also, the cross-sectional nature of our study precluded our ability to fully explore the possibility that some
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OPXV-seropositive persons may have had sub-clinical OPXV
infections, a question better addressed in a prospective investigation. Other limitations preventing broader interpretation of
our study findings include the fact that not all questions were
answered by all participants, and that our survey investigation
tool was insufficient to capture reliable (non-biased) individual responses to questions about animal exposure.
In summary, the accumulated findings from this study lead us
to conclude that no one species of animal and neither collection
site could be strongly implicated, nor dismissed, as being the
source for the MPXV imported into the United States in 2003.
Rather, our results are suggestive of geographically widespread
exposure to OPX among rodents found at both sites, near both
communities surveyed, leading us to postulate that persons living in these communities may have enduring, but potentially
low-intensity or indirect, exposure to OPXV- infected animals
resulting in sub-clinical (i.e., asymptomatic) infection concomitant with seroconversion. Possibilities for exposure are likely to
begin at a young age, with additional risks present for children
living in heavily forested areas. The presence of substantial
clinical illness associated with MPXV infection among persons in the United States might be explained by the virus having passed through an amplification host, namely prairie dogs.
Contact with MPXV-infected prairie dogs was identified in
each instance of human infection, whereas no persons coming
into contact with infected African rodents became infected.22
We cannot discount the possibility that other uncharacterized
OPXVs are also circulating in southern Ghana. This possibility
should also be thoroughly explored.
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